Navigation Links
Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
Date:4/1/2013

d elevated apoC-III.   Following the completion of the Phase 2 study, we plan to move rapidly into a Phase 3 study in the most severe patients with triglyceride levels greater than 880 mg/dL who are unable to reach acceptable triglyceride levels with currently available treatments."

In the published data, treatment with an antisense compound targeting apoC-III produced a variety of potential cardio-protective effects including significant dose-dependent reductions of apoC-III and triglycerides in all models and species, including man.  In addition, treatment with an antisense compound targeting apoC-III resulted in enhanced triglyceride clearance from blood following a high-fat meal, reduction of VLDL particles and a slight increase in HDL-C levels.  In all models and in the Phase 1 study, antisense inhibition of apoC-III was well tolerated.  These data were consistent across multiple preclinical models and species and in a Phase 1 study in healthy volunteers demonstrating that Isis' antisense technology was able to produce predictable and consistent responses among different animal models that translate into corresponding activity in man. In the Phase 1 study, treatment with ISIS-APOCIIIRx was well tolerated and produced rapid, dose-dependent median reductions of up to 44 percent in plasma triglycerides and up to 78 percent in apoC-III protein, with two out of the three subjects in the highest dose group achieving undetectable levels of apoC-III. 

ABOUT ISIS-APOCIIIRx
ISIS-APOCIIIRx inhibits the production of apoC-III, a traditionally 'undruggable' target that inhibits the clearance of triglycerides from the blood. People who do not produce apoC-III have lower levels of triglycerides and lower instances of cardiovascular disease. ApoC-III is elevated in patients with dyslipidemia, or an abnormal concentration of lipids in the blood, and is frequently associated with multiple metabolic
'/>"/>

SOURCE Isis Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
2. Bloomberg BNA Publishes Sixth Edition of False Claims Act Treatise
3. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
4. Specialty Pharmacy Association of America (SPAARx) Publishes Definition of Specialty Pharmacy
5. Camfil Farr Publishes FAQ on HEPA Air Filters
6. French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
7. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
8. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
9. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
10. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
11. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015   Intarcia Therapeutics, Inc. today ... as Vice President, Human Resources, reporting directly to ... a new key member of the senior leadership team, ... Leadership Team to assure the Company advances its business, ... its core values and its dynamic culture. Another essential ...
(Date:5/1/2015)... 2015 CANTEL MEDICAL CORP. (NYSE: CMN ) ... Officer, will be presenting at the Bank of America Merrill ... in Las Vegas, NV. The formal ... AM PT/1:00 PM ET. In addition, management will be available ... An audio webcast will be available via the investor relations ...
(Date:5/1/2015)... 2015  Portal Instruments, Inc., an emerging leader in ... that Robert Langer, Sc. D., MIT Institute Professor, ... Distinguished Professor have joined the company,s Scientific Advisory Board. ... biotechnology leaders, Professor Robert Langer and Professor ... Patrick Anquetil , Chief Executive Officer of Portal ...
Breaking Medicine Technology:Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4
... level of injury is key to treating MCLs nonsurgically, ... to the knee,s medial cruciate ligament (MCL) may be ... published in the March 2009 issue of The ... (JAAOS) . The key, the review,s authors found, ...
... 2 Aerovance Inc. today announced that it ... Drug Administration (FDA) and the U.K. Medicines and ... Phase IIb clinical trial, AeroTrial(TM), of inhaled dry ... begins today in the United States for AeroTrial, ...
Cached Medicine Technology:Treating Knee Ligament Injuries 2Treating Knee Ligament Injuries 3Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 2Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 3
(Date:5/3/2015)... Burnsville MN (PRWEB) May 03, 2015 ... in workplace safety solutions, announces its appearance at the ... Health Conference. Products that HealthPostures will exhibit at the ... Largest of the sit stand solutions is the 6100 ... push button height control, an adjustable keyboard tray, extended ...
(Date:5/2/2015)... ProText Kinetic 2 is a set of typography ... X. ProText Kinetic 2 features 40 animation presets ... X . Easily create interactive text videos without having ... Kinetic 2. , Using ProText Kinetic is as easy as ... presets in the FCPX timeline. Playback the default animation ...
(Date:5/2/2015)... IL (PRWEB) May 02, 2015 Kare Visits ... provide support for busy caregivers. Kare Visits offers relief ... and assisted living facilities. According to the Caregiver ... spend an average of 20 hours a week caring for ... of the cost to hire a nurse, a caregiver is ...
(Date:5/1/2015)... 02, 2015 The Venetian on Grace ... http://www.thevenetiangracebay.com , and it is elegant and sophisticated, like ... and attractive turquoise hues of Grace Bay Beach. ... percent of leisure travelers used their smartphones throughout the ... used in the planning and researching and continued through ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 TROY Healthcare ... Cerner Southeast Regional User Group (RUG) Conference in Atlanta, ... Southeast Regional User Group Conference provides a forum for ... who support all aspects of electronic medical record operations, ... Cerner software applications. , In addition to sponsoring the ...
Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... Pa., May 29 West Pharmaceutical Services, Inc. (NYSE: ... Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and ... the 2009 UBS Global Specialty Pharmaceuticals Conference at 9:00 ... England. A copy of the corporate presentation document will ...
... 29 Britannia members overwhelmingly endorse plans to ... create new super-mutual:- New business will be the ... providing ethical alternative to banks- Strong strategic and ... efficiency and revenue benefits of pounds Sterling 60 ...
... Eli Lilly and Company (NYSE: ... Agency,s (EMEA) Committee for Medicinal Products for Human Use ... of ALIMTA(R) (pemetrexed for injection) as monotherapy for the ... lung cancer (NSCLC) with other than predominantly squamous cell ...
... Environment and Long-Term Care to Youth with Special NeedsWASHINGTON, May ... 125th anniversary with the launch of Home at HSC ... a home environment for long-term patients age 6 months to ... to provide in a home, group home or typical long-term ...
... Alzheimer,s researchers have co-edited a book critically synthesizing the ... Alzheimer,s disease. Building upon a 2007 Alzheimer,s disease ... College of Sciences at The University of Texas at ... at The University of Chile Medical School have edited ...
... of chemotherapies 5FU and oxaliplatin compared to 5FU alone ... and promotes longer survival for patients under 70 -- ... Mayo Clinic and Dana-Farber Cancer Institute scientists who will ... Oncology,s (ASCO) annual meeting in Orlando, Fla. , "By ...
Cached Medicine News:Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 2Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 3Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 4Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 3Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 4Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 5Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 6Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 7Health News:Home At HSC 2Health News:UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimer's research 2Health News:Chemotherapy combination outcomes differ for aged, younger colon cancer patients 2Health News:Chemotherapy combination outcomes differ for aged, younger colon cancer patients 3
Surgical-grade stainless steel disposable concentric needle with Trocar tip has an insulated platinum-alloy core and two attached 61-cm (24-in) lead wires. Needles sold in packages of 20....
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... delivers excellent sensitivity and specificity for the diagnosis ... test that provides an answer in 6 minutes. ... provide improved patient care with a test that ... out what value we bring to your daily ...
... are made of PTFE coated stainless ... tip, which ensures low friction at ... turn, provides significantly improved patient comfort. ... design for easy and secure grip. ...
Medicine Products: